Past, Current, and Future of Immunotherapies for Prostate Cancer

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy

Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response

Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.

Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment

On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy

Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome

Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy

Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials

Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time